
Clearside Biomedical Investor Relations Material
Latest events

Q3 2024
Clearside Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Clearside Biomedical Inc
Access all reports
Clearside Biomedical, Inc. is a biopharmaceutical company specializing in the development of therapies for the treatment of eye diseases. The company focuses on treating conditions affecting the retina and choroid through its proprietary SCS Microinjector platform, which delivers drugs directly to the back of the eye. Clearside's approach aims to enhance the efficacy of treatments for serious vision-threatening diseases, including macular edema and uveitis. The company is headquartered in Alpharetta, United States, and its shares are listed on the NASDAQ.
Key slides for Clearside Biomedical Inc


The Citizens JMP Life Sciences Conference
Clearside Biomedical Inc


Study Result
Clearside Biomedical Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
CLSD
Country
🇺🇸 United States